(Q41065499)

English

Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

H Modjtahedi

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

T Komurasaki

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

H Toyoda

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

C Dean

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

310-316

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Monoclonal antibodies to the EGF receptor act as betacellulin antagonists

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Use of Bacillus brevis for efficient synthesis and secretion of human epidermal growth factor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980119%2975%3A2%3C310%3A%3AAID-IJC22%3E3.0.CO%3B2-F

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19980119)75:2<310::AID-IJC22>3.0.CO;2-F

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

release_mjisfzizvrc5nae2hdj7a53xla

1 reference

https://api.fatcat.wiki/v0/release/mjisfzizvrc5nae2hdj7a53xla

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41065499&oldid=1914270948"